News

Roche Presents New Insights In Alzheimer's Disease Research Across Its Diagnostics And Pharmaceutical Portfolios At AAIC

Trontinemab's Phase Ib/IIa BrainshuttleTM AD study continues to show rapid and robust clearance of amyloid p ...